X PARSOLEX PARTNER SOLUTIONS EXCELLENCE
Live / Registered — Registered (as of 18 May 2021)
What this means for you
Registered since 18 May 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88570495
- Registration number
- 6356728
- Mark type
- Design + words
- Filed
- 07 Aug 2019
- Published for opposition
- 28 Jul 2020
- Registered
- 18 May 2021
- Attorney of record
- Jill J. Chalmers
Goods and services
- Class 035 — Advertising and business services: Market assessment services; consulting services, namely, providing market research and business analysis services in the pharmaceutical, medical and healthcare fields; business consulting and planning services in the field of pharmaceuticals, medicine and healthcare; business consulting and planning services in the field of the commercialization of pharmaceuticals, medicines and healthcare products; business consulting services relating to product distribution, operations management services, logistics, reverse logistics, supply chain, and production systems and distribution solutions; consulting in the fields of sales methods, sales management, and sales improvement; business consultation; business administration consultation services; business operation consultation services; business consulting services in the field of pharmaceutical manufacturing, pharmaceutical packaging, and distribution; business consulting in the pharmaceutical products, medical and healthcare industries; business consulting, business management, business advisory services; marketing consulting services in the field of pharmaceuticals, medicine and healthcare; business marketing consulting services; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; branding and marketing services for others in the field of pharmaceutical, medical, and healthcare industries; regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; advertising of custom services for pharmaceutical formulation design, design of processes to transform inorganic and organic substances, scale-up of pharmaceutical manufacturing processes, pharmaceutical technology transfer, manufacture of pharmaceuticals, and chemical and physical evaluation of pharmaceuticals for others; distributorship services of pharmaceutical and medical products for others; commercialization of pharmaceuticals and medical products for others
- Class 045 — Legal and security services: Consulting services in the field of regulatory compliance in the pharmaceutical, medical and healthcare industries; regulatory services for others, namely, tracking and monitoring regulatory requirements in the field of the pharmaceutical, medical, and healthcare industries for regulatory compliance purposes
Owner
- Parsolex GMP Center, Inc., West Lafayette, IN, US
- Parsolex GMP Center, Inc., West Lafayette, IN, US
- Parsolex GMP Center, Inc., West Lafayette, IN, US
Prosecution history
- 18 May 2021 — REGISTERED-PRINCIPAL REGISTER
- 16 Apr 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 15 Apr 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Apr 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 17 Mar 2021 — USE AMENDMENT FILED
- 01 Apr 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 17 Mar 2021 — TEAS STATEMENT OF USE RECEIVED
- 22 Sept 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 Jul 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Jul 2020 — PUBLISHED FOR OPPOSITION
- 08 Jul 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 24 Jun 2020 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 16 Jun 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Jun 2020 — EXAMINER'S AMENDMENT ENTERED
- 16 Jun 2020 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED